Titre : Manifestations neuromusculaires

Manifestations neuromusculaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognition
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Manifestations neuromusculaires : Questions médicales les plus fréquentes", "headline": "Manifestations neuromusculaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Manifestations neuromusculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-13", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Manifestations neuromusculaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Manifestations neurologiques", "url": "https://questionsmedicales.fr/mesh/D009461", "about": { "@type": "MedicalCondition", "name": "Manifestations neurologiques", "code": { "@type": "MedicalCode", "code": "D009461", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Fasciculation", "alternateName": "Fasciculation", "url": "https://questionsmedicales.fr/mesh/D005207", "about": { "@type": "MedicalCondition", "name": "Fasciculation", "code": { "@type": "MedicalCode", "code": "D005207", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.250" } } }, { "@type": "MedicalWebPage", "name": "Crampe musculaire", "alternateName": "Muscle Cramp", "url": "https://questionsmedicales.fr/mesh/D009120", "about": { "@type": "MedicalCondition", "name": "Crampe musculaire", "code": { "@type": "MedicalCode", "code": "D009120", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.500" } } }, { "@type": "MedicalWebPage", "name": "Hypertonie musculaire", "alternateName": "Muscle Hypertonia", "url": "https://questionsmedicales.fr/mesh/D009122", "about": { "@type": "MedicalCondition", "name": "Hypertonie musculaire", "code": { "@type": "MedicalCode", "code": "D009122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Raideur musculaire", "alternateName": "Muscle Rigidity", "url": "https://questionsmedicales.fr/mesh/D009127", "about": { "@type": "MedicalCondition", "name": "Raideur musculaire", "code": { "@type": "MedicalCode", "code": "D009127", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.550.500" } } }, { "@type": "MedicalWebPage", "name": "Spasticité musculaire", "alternateName": "Muscle Spasticity", "url": "https://questionsmedicales.fr/mesh/D009128", "about": { "@type": "MedicalCondition", "name": "Spasticité musculaire", "code": { "@type": "MedicalCode", "code": "D009128", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.550.550" } } } ] }, { "@type": "MedicalWebPage", "name": "Hypotonie musculaire", "alternateName": "Muscle Hypotonia", "url": "https://questionsmedicales.fr/mesh/D009123", "about": { "@type": "MedicalCondition", "name": "Hypotonie musculaire", "code": { "@type": "MedicalCode", "code": "D009123", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.575" } } }, { "@type": "MedicalWebPage", "name": "Faiblesse musculaire", "alternateName": "Muscle Weakness", "url": "https://questionsmedicales.fr/mesh/D018908", "about": { "@type": "MedicalCondition", "name": "Faiblesse musculaire", "code": { "@type": "MedicalCode", "code": "D018908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.593" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de la tête tombante", "alternateName": "Dropped Head Syndrome", "url": "https://questionsmedicales.fr/mesh/D000094222", "about": { "@type": "MedicalCondition", "name": "Syndrome de la tête tombante", "code": { "@type": "MedicalCode", "code": "D000094222", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.593.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Amyotrophie", "alternateName": "Muscular Atrophy", "url": "https://questionsmedicales.fr/mesh/D009133", "about": { "@type": "MedicalCondition", "name": "Amyotrophie", "code": { "@type": "MedicalCode", "code": "D009133", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.612" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sarcopénie", "alternateName": "Sarcopenia", "url": "https://questionsmedicales.fr/mesh/D055948", "about": { "@type": "MedicalCondition", "name": "Sarcopénie", "code": { "@type": "MedicalCode", "code": "D055948", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.612.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Myokymie", "alternateName": "Myokymia", "url": "https://questionsmedicales.fr/mesh/D020385", "about": { "@type": "MedicalCondition", "name": "Myokymie", "code": { "@type": "MedicalCode", "code": "D020385", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.650" } } }, { "@type": "MedicalWebPage", "name": "Myotonie", "alternateName": "Myotonia", "url": "https://questionsmedicales.fr/mesh/D009222", "about": { "@type": "MedicalCondition", "name": "Myotonie", "code": { "@type": "MedicalCode", "code": "D009222", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.700" } } }, { "@type": "MedicalWebPage", "name": "Spasme", "alternateName": "Spasm", "url": "https://questionsmedicales.fr/mesh/D013035", "about": { "@type": "MedicalCondition", "name": "Spasme", "code": { "@type": "MedicalCode", "code": "D013035", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Spasme hémifacial", "alternateName": "Hemifacial Spasm", "url": "https://questionsmedicales.fr/mesh/D019569", "about": { "@type": "MedicalCondition", "name": "Spasme hémifacial", "code": { "@type": "MedicalCode", "code": "D019569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.750.400" } } }, { "@type": "MedicalWebPage", "name": "Trismus", "alternateName": "Trismus", "url": "https://questionsmedicales.fr/mesh/D014313", "about": { "@type": "MedicalCondition", "name": "Trismus", "code": { "@type": "MedicalCode", "code": "D014313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.750.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Tétanie", "alternateName": "Tetany", "url": "https://questionsmedicales.fr/mesh/D013746", "about": { "@type": "MedicalCondition", "name": "Tétanie", "code": { "@type": "MedicalCode", "code": "D013746", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Manifestations neuromusculaires", "alternateName": "Neuromuscular Manifestations", "code": { "@type": "MedicalCode", "code": "D020879", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael S Cartwright", "url": "https://questionsmedicales.fr/author/Michael%20S%20Cartwright", "affiliation": { "@type": "Organization", "name": "Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA." } }, { "@type": "Person", "name": "Heinz Jungbluth", "url": "https://questionsmedicales.fr/author/Heinz%20Jungbluth", "affiliation": { "@type": "Organization", "name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk." } }, { "@type": "Person", "name": "David Lacomis", "url": "https://questionsmedicales.fr/author/David%20Lacomis", "affiliation": { "@type": "Organization", "name": "Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States." } }, { "@type": "Person", "name": "Miguel A Fernandez-Garcia", "url": "https://questionsmedicales.fr/author/Miguel%20A%20Fernandez-Garcia", "affiliation": { "@type": "Organization", "name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom." } }, { "@type": "Person", "name": "Ruple S Laughlin", "url": "https://questionsmedicales.fr/author/Ruple%20S%20Laughlin", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36424289", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.schres.2022.11.004" } }, { "@type": "ScholarlyArticle", "name": "Treatment preferences among adults with normal cognition and cognitive impairment.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36094330", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jgs.18032" } }, { "@type": "ScholarlyArticle", "name": "Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36634906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuroscience.2023.01.004" } }, { "@type": "ScholarlyArticle", "name": "Deep Cognitive Gate: Resembling Human Cognition for Saliency Detection.", "datePublished": "2022-08-04", "url": "https://questionsmedicales.fr/article/33755558", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1109/TPAMI.2021.3068277" } }, { "@type": "ScholarlyArticle", "name": "Effects of cognitive stimulation program on cognition and mood in older adults, stratified by cognitive levels: A randomized controlled trial.", "datePublished": "2023-03-04", "url": "https://questionsmedicales.fr/article/36921506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.archger.2023.104984" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Manifestations neuromusculaires", "item": "https://questionsmedicales.fr/mesh/D020879" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Manifestations neuromusculaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Manifestations neuromusculaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Manifestations neuromusculaires", "description": "Comment diagnostiquer une myopathie ?\nQuels examens pour les neuropathies ?\nQuel rôle des tests génétiques ?\nComment évaluer la force musculaire ?\nQuand faire une IRM musculaire ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cognition&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Manifestations neuromusculaires", "description": "Quels sont les symptômes d'une dystrophie musculaire ?\nComment se manifeste une neuropathie périphérique ?\nQuels signes d'une myasthénie ?\nQuels symptômes d'une sclérose latérale amyotrophique ?\nComment reconnaître un syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cognition&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Manifestations neuromusculaires", "description": "Peut-on prévenir les neuropathies ?\nComment prévenir les crampes musculaires ?\nY a-t-il des mesures préventives pour la myopathie ?\nComment éviter les blessures musculaires ?\nPeut-on prévenir la sclérose latérale amyotrophique ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cognition&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Manifestations neuromusculaires", "description": "Quels traitements pour la myopathie ?\nComment traiter une neuropathie diabétique ?\nQuel est le traitement de la myasthénie ?\nQuelles options pour la sclérose latérale amyotrophique ?\nComment gérer le syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cognition&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Manifestations neuromusculaires", "description": "Quelles complications des myopathies ?\nQuels risques avec la neuropathie ?\nQuelles complications de la myasthénie ?\nQuels problèmes liés à la sclérose latérale amyotrophique ?\nQuelles complications du syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cognition&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Manifestations neuromusculaires", "description": "Quels facteurs de risque pour les myopathies ?\nQuels risques pour la neuropathie diabétique ?\nQuels facteurs de risque pour la myasthénie ?\nQuels risques pour la sclérose latérale amyotrophique ?\nQuels facteurs de risque pour le syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Cognition&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une myopathie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de myopathie nécessite un examen clinique, des tests sanguins et une biopsie musculaire." } }, { "@type": "Question", "name": "Quels examens pour les neuropathies ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les neuropathies sont diagnostiquées par électromyogramme (EMG) et études de conduction nerveuse." } }, { "@type": "Question", "name": "Quel rôle des tests génétiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests génétiques aident à identifier des maladies neuromusculaires héréditaires spécifiques." } }, { "@type": "Question", "name": "Comment évaluer la force musculaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La force musculaire est évaluée par des tests de force manuelle et des échelles standardisées." } }, { "@type": "Question", "name": "Quand faire une IRM musculaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM musculaire est indiquée pour visualiser des anomalies structurelles dans les muscles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une dystrophie musculaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire progressive, crampes et difficultés à marcher." } }, { "@type": "Question", "name": "Comment se manifeste une neuropathie périphérique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs, des picotements et une perte de sensation dans les membres." } }, { "@type": "Question", "name": "Quels signes d'une myasthénie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fatigue musculaire, ptosis (chute des paupières) et troubles de la déglutition." } }, { "@type": "Question", "name": "Quels symptômes d'une sclérose latérale amyotrophique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, crampes et difficultés à parler et à avaler." } }, { "@type": "Question", "name": "Comment reconnaître un syndrome de Guillain-Barré ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il se manifeste par une faiblesse musculaire rapide, des picotements et des réflexes diminués." } }, { "@type": "Question", "name": "Peut-on prévenir les neuropathies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut le contrôle des maladies chroniques comme le diabète et l'évitement des toxines." } }, { "@type": "Question", "name": "Comment prévenir les crampes musculaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation, l'étirement régulier et une alimentation équilibrée aident à prévenir les crampes." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour la myopathie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de prévention spécifique, mais un diagnostic précoce peut aider à gérer les symptômes." } }, { "@type": "Question", "name": "Comment éviter les blessures musculaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un échauffement adéquat, des exercices appropriés et une bonne technique réduisent les blessures." } }, { "@type": "Question", "name": "Peut-on prévenir la sclérose latérale amyotrophique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de méthode prouvée pour prévenir la sclérose latérale amyotrophique." } }, { "@type": "Question", "name": "Quels traitements pour la myopathie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des corticostéroïdes, de la physiothérapie et des médicaments immunosuppresseurs." } }, { "@type": "Question", "name": "Comment traiter une neuropathie diabétique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend le contrôle de la glycémie, des analgésiques et des thérapies physiques." } }, { "@type": "Question", "name": "Quel est le traitement de la myasthénie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des inhibiteurs de l'acétylcholinestérase et parfois des immunosuppresseurs." } }, { "@type": "Question", "name": "Quelles options pour la sclérose latérale amyotrophique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent des médicaments pour ralentir la progression et des soins palliatifs." } }, { "@type": "Question", "name": "Comment gérer le syndrome de Guillain-Barré ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des immunoglobulines intraveineuses et une rééducation physique." } }, { "@type": "Question", "name": "Quelles complications des myopathies ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des déformations squelettiques, des problèmes respiratoires et cardiaques." } }, { "@type": "Question", "name": "Quels risques avec la neuropathie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des blessures dues à une perte de sensation et des infections cutanées." } }, { "@type": "Question", "name": "Quelles complications de la myasthénie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des crises myasthéniques, affectant la respiration et la déglutition." } }, { "@type": "Question", "name": "Quels problèmes liés à la sclérose latérale amyotrophique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les problèmes incluent la paralysie progressive, des difficultés respiratoires et des infections." } }, { "@type": "Question", "name": "Quelles complications du syndrome de Guillain-Barré ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des problèmes respiratoires, des douleurs chroniques et des séquelles neurologiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les myopathies ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections virales et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels risques pour la neuropathie diabétique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète mal contrôlé, l'obésité et l'hypertension augmentent le risque de neuropathie." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la myasthénie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux." } }, { "@type": "Question", "name": "Quels risques pour la sclérose latérale amyotrophique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent l'âge avancé, le sexe masculin et des antécédents familiaux." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le syndrome de Guillain-Barré ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les infections virales, notamment la grippe, et des antécédents de vaccination peuvent être des facteurs de risque." } } ] } ] }

Sources (10000 au total)

Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.

Schizophrenia is associated with an elevated risk for impulsive aggression for which there are few psychosocial treatment options. Neurocognitive and social cognitive deficits have been associated wit... The two-center study randomized 130 participants to receive 36 sessions of either a combination of cognitive remediation and social cognition treatment or cognitive remediation plus a computer-based c... Study participants were mostly male (84.5 %), had a mean age 34.9 years, and 11.5 years of education. Both Cognitive Remediation Training (CRT) plus Social Cognition Training (SCT) and CRT plus contro... CRT proved to be an effective non-pharmacological treatment in reducing impulsive aggression in schizophrenia inpatient participants with a history of aggressive episodes. The addition of social cogni...

Treatment preferences among adults with normal cognition and cognitive impairment.

Although patient participation in treatment decisions is important for preference-concordant care delivery, it is largely unknown how cognitive impairment influences treatment preferences. We investig... Data from the 2018 Health and Retirement Study were used. The sample included 1291 self-respondents (201 respondents with cognitive impairment, and 1090 with normal cognition). We examined treatment p... Respondents with cognitive impairment were more likely to report that they were unsure about treatment options across both clinical scenarios compared to those with normal cognition. For the limited t... Compared to those with normal cognition, cognitive impairment was associated with greater uncertainty about treatment preferences and higher rates of aggressive care preferences among those who specif...

Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.

Subjective cognitive decline (SCD) and objective subtle cognitive difficulties (Obj-SCD) are considered the initial stages of aberrant cognition prior to mild cognitive impairment (MCI) due to Alzheim...

Effects of cognitive stimulation program on cognition and mood in older adults, stratified by cognitive levels: A randomized controlled trial.

Cognitive stimulation (CS) is defined as activities that involve cognitive processing, usually conducted in a social context and often in a group. This study aims to evaluate the effects of a personal... The randomized controlled single-blind trial involving 337 participants (235 women and 102 men) ≥ 65 years of age in a Primary Care centre classified participants into 4 groups: 101 for the no deterio... The intervention showed a tendency of improvement on global cognition and different cognitive functions for groups with no deterioration or level deterioration. The group with moderate deterioration i... The findings demonstrated benefits in global cognition, different cognitive functions, semantic fluency, IADLs and anxiety. The most benefits are given in the intermediate groups, SCI, and LD. Moreove...

The Effect of Hearing Loss on Cognitive Function in Subjective Cognitive Decline.

Subjective cognitive decline (SCD) is a self-reported cognitive decline without objective cognitive impairment. The relationship between audiometric hearing loss (HL) and cognitive function has not be... This is a cross-sectional study that used the baseline data of a multicenter cohort study that monitors clinical progression from SCD to dementia. Individuals aged ≥60 years who reported cognitive dec... Of a total of 120 participants, one hundred and two had NH (n = 57) or bilateral HL (n = 45). There were no group differences in the demographic and clinical data except the age. The biomarkers, globa... In SCD, HL exerted an adverse effect on cognitive function, primarily frontal executive function tested in the Stroop task. HL was also related to gray matter volume reductions in brain subregions, al...

Physical and cognitive function to explain the quality of life among older adults with cognitive impairment: exploring cognitive function as a mediator.

Physical and cognitive function are both indicators of aging, characterized by a loss of adaptive response to life challenges and functional limitations, subsequently affecting their quality of life. ... The study participants were 79 older adults recruited from community centers in four urban districts of Korea. All participants completed a self-reported questionnaire for demographic characteristics ... The mean age of participants was 77.46 years old with an elementary or lower education level (53.2%). The mean score of cognitive function was 16.39 (SD = 6.5). Physical function (grip strength, balan... In conclusion, physical and cognitive function were significant predictors of QOL in older adults with cognitive impairment. Specifically, balance has significant indirect effects on the physical comp...

Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.

Both Alzheimer's disease (AD) genetic risk factors and indices of cognitive reserve (CR) influence risk of cognitive decline, but it remains unclear whether they interact. This study examined whether ... Analyses used data from the Preclinical AD Consortium, including harmonized data from 5 longitudinal cohort studies. Participants were cognitively normal at baseline (M baseline age = 64 years, 59% fe... In mixed-effects models, higher CR index scores were associated with better baseline cognitive performance for all cognitive outcomes. APOE-ε4 genotype and AD-PRS that included the APOE region (AD-PRS... These results suggest that APOE-ε4 and non-APOE-ε4 AD polygenic risk are independently associated with global cognitive and executive function declines among individuals with normal cognition at basel...

The use of subjective cognitive complaints for detecting mild cognitive impairment in older adults across cultural and linguistic groups: A comparison of the Cognitive Function Instrument to the Montreal Cognitive Assessment.

This pilot study aims to explore the psychometric properties of the Cognitive Function Instrument (CFI) as a measure of subjective cognitive complaints (SCC) and its performance in distinguishing mild... One hundred ninety-four community-dwelling non-demented older adults with racial/ethnic diversity were included. Unidimensionality and internal consistency of the CFI were examined using factor analys... The CFI demonstrated adequate internal consistency; however, the fit for a unidimensional model was suboptimal. The CFI distinguished MCI from NC alone or in combination with MoCA. ROC analysis showed... Our findings support the use of CFI as a brief and easy-to-use screen to detect MCI in culturally/linguistically diverse older adults.... What is the key scientific question or problem of central interest of the paper? Subjective cognitive complaints (SCCs) are considered the earliest sign of dementia in older adults. However, it is unc...